HEADER HYDROLASE/HYDROLASE INHIBITOR 16-MAR-19 6OAL TITLE STRUCTURE OF HUMAN PARG COMPLEXED WITH JA2120 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY(ADP-RIBOSE) GLYCOHYDROLASE; COMPND 3 CHAIN: A; COMPND 4 EC: 3.2.1.143; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.A.BROSEY,Z.AHMED,S.WARDEN,J.A.TAINER REVDAT 3 11-OCT-23 6OAL 1 REMARK REVDAT 2 27-MAY-20 6OAL 1 JRNL REVDAT 1 18-MAR-20 6OAL 0 JRNL AUTH J.H.HOUL,Z.YE,C.A.BROSEY,L.P.F.BALAPITI-MODARAGE,S.NAMJOSHI, JRNL AUTH 2 A.BACOLLA,D.LAVERTY,B.L.WALKER,Y.POURFARJAM,L.S.WARDEN, JRNL AUTH 3 N.BABU CHINNAM,D.MOIANI,R.A.STEGEMAN,M.K.CHEN,M.C.HUNG, JRNL AUTH 4 Z.D.NAGEL,T.ELLENBERGER,I.K.KIM,D.E.JONES,Z.AHMED,J.A.TAINER JRNL TITL SELECTIVE SMALL MOLECULE PARG INHIBITOR CAUSES REPLICATION JRNL TITL 2 FORK STALLING AND CANCER CELL DEATH. JRNL REF NAT COMMUN V. 10 5654 2019 JRNL REFN ESSN 2041-1723 JRNL PMID 31827085 JRNL DOI 10.1038/S41467-019-13508-4 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.96 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 74154 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.970 REMARK 3 FREE R VALUE TEST SET COUNT : 3687 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.9742 - 4.7369 1.00 2893 173 0.1974 0.1905 REMARK 3 2 4.7369 - 3.7610 1.00 2810 146 0.1552 0.1977 REMARK 3 3 3.7610 - 3.2859 1.00 2774 144 0.1720 0.1852 REMARK 3 4 3.2859 - 2.9856 1.00 2719 164 0.1769 0.2152 REMARK 3 5 2.9856 - 2.7717 1.00 2702 155 0.1763 0.2182 REMARK 3 6 2.7717 - 2.6083 1.00 2764 130 0.1662 0.1751 REMARK 3 7 2.6083 - 2.4777 1.00 2706 141 0.1696 0.2136 REMARK 3 8 2.4777 - 2.3699 1.00 2719 136 0.1670 0.2303 REMARK 3 9 2.3699 - 2.2787 1.00 2695 154 0.1616 0.1979 REMARK 3 10 2.2787 - 2.2001 1.00 2730 124 0.1644 0.1805 REMARK 3 11 2.2001 - 2.1313 1.00 2700 126 0.1653 0.2088 REMARK 3 12 2.1313 - 2.0704 1.00 2730 120 0.1680 0.1820 REMARK 3 13 2.0704 - 2.0159 1.00 2682 138 0.1693 0.2065 REMARK 3 14 2.0159 - 1.9667 1.00 2700 136 0.1723 0.2185 REMARK 3 15 1.9667 - 1.9220 1.00 2706 138 0.1777 0.2073 REMARK 3 16 1.9220 - 1.8811 1.00 2679 150 0.1894 0.2065 REMARK 3 17 1.8811 - 1.8434 1.00 2697 134 0.2067 0.2594 REMARK 3 18 1.8434 - 1.8087 1.00 2694 153 0.2167 0.2437 REMARK 3 19 1.8087 - 1.7764 1.00 2634 143 0.2384 0.2760 REMARK 3 20 1.7764 - 1.7462 1.00 2694 123 0.2415 0.2838 REMARK 3 21 1.7462 - 1.7181 1.00 2700 143 0.2531 0.3005 REMARK 3 22 1.7181 - 1.6916 1.00 2696 145 0.2581 0.2930 REMARK 3 23 1.6916 - 1.6668 1.00 2666 132 0.2677 0.2974 REMARK 3 24 1.6668 - 1.6433 1.00 2680 140 0.2795 0.3017 REMARK 3 25 1.6433 - 1.6211 1.00 2644 156 0.3011 0.3880 REMARK 3 26 1.6211 - 1.6000 1.00 2653 143 0.3162 0.3582 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.650 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 4156 REMARK 3 ANGLE : 1.009 5647 REMARK 3 CHIRALITY : 0.055 610 REMARK 3 PLANARITY : 0.006 730 REMARK 3 DIHEDRAL : 12.610 2506 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6OAL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-MAR-19. REMARK 100 THE DEPOSITION ID IS D_1000240308. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-DEC-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 74163 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 36.964 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 19.80 REMARK 200 R MERGE (I) : 0.11800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.5900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 3.58200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4B1G REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M PCTP, PH 7.5, 0.2 M (NH3)2SO4, REMARK 280 17% PEG3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.15100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.14500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.52650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.14500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.15100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.52650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 448 REMARK 465 PRO A 449 REMARK 465 PRO A 522 REMARK 465 VAL A 523 REMARK 465 GLU A 524 REMARK 465 ASP A 525 REMARK 465 GLU A 526 REMARK 465 ASN A 527 REMARK 465 GLY A 528 REMARK 465 GLU A 529 REMARK 465 ARG A 530 REMARK 465 THR A 531 REMARK 465 SER A 944 REMARK 465 THR A 945 REMARK 465 PRO A 946 REMARK 465 SER A 962 REMARK 465 CYS A 963 REMARK 465 ALA A 964 REMARK 465 GLU A 965 REMARK 465 THR A 966 REMARK 465 ALA A 967 REMARK 465 ASP A 968 REMARK 465 HIS A 969 REMARK 465 SER A 970 REMARK 465 GLY A 971 REMARK 465 GLN A 972 REMARK 465 ARG A 973 REMARK 465 THR A 974 REMARK 465 GLY A 975 REMARK 465 THR A 976 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 450 CG OD1 OD2 REMARK 470 LYS A 451 CG CD CE NZ REMARK 470 MET A 464 CG SD CE REMARK 470 ILE A 469 CG1 CG2 CD1 REMARK 470 ARG A 470 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 473 CG CD1 CD2 REMARK 470 ARG A 475 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 490 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 503 CG CD CE NZ REMARK 470 LYS A 546 CG CD CE NZ REMARK 470 LYS A 566 CG CD CE NZ REMARK 470 LYS A 616 CG CD CE NZ REMARK 470 GLN A 617 CG CD OE1 NE2 REMARK 470 LYS A 618 CG CD CE NZ REMARK 470 LYS A 648 CG CD CE NZ REMARK 470 ARG A 684 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 688 CG CD OE1 OE2 REMARK 470 LYS A 689 CG CD CE NZ REMARK 470 LYS A 690 CG CD CE NZ REMARK 470 ASP A 704 CG OD1 OD2 REMARK 470 ARG A 830 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 831 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 860 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 544 48.31 -89.16 REMARK 500 ASN A 561 43.55 -141.58 REMARK 500 SER A 592 -61.80 -125.87 REMARK 500 CYS A 608 74.48 -101.81 REMARK 500 LYS A 618 -2.91 78.46 REMARK 500 THR A 716 -169.51 -101.59 REMARK 500 SER A 749 -117.69 -134.16 REMARK 500 LEU A 752 69.60 -161.65 REMARK 500 VAL A 753 -150.39 -124.24 REMARK 500 ALA A 796 -121.93 46.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1458 DISTANCE = 5.81 ANGSTROMS REMARK 525 HOH A1459 DISTANCE = 5.87 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue M0P A 1001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6O9X RELATED DB: PDB REMARK 900 RELATED ID: 6O9Y RELATED DB: PDB REMARK 900 RELATED ID: 6OA0 RELATED DB: PDB REMARK 900 RELATED ID: 6OA1 RELATED DB: PDB REMARK 900 RELATED ID: 6OA3 RELATED DB: PDB REMARK 900 RELATED ID: 6OAK RELATED DB: PDB DBREF 6OAL A 448 976 UNP Q86W56 PARG_HUMAN 448 976 SEQRES 1 A 529 SER PRO ASP LYS LYS TRP LEU GLY THR PRO ILE GLU GLU SEQRES 2 A 529 MET ARG ARG MET PRO ARG CYS GLY ILE ARG LEU PRO LEU SEQRES 3 A 529 LEU ARG PRO SER ALA ASN HIS THR VAL THR ILE ARG VAL SEQRES 4 A 529 ASP LEU LEU ARG ALA GLY GLU VAL PRO LYS PRO PHE PRO SEQRES 5 A 529 THR HIS TYR LYS ASP LEU TRP ASP ASN LYS HIS VAL LYS SEQRES 6 A 529 MET PRO CYS SER GLU GLN ASN LEU TYR PRO VAL GLU ASP SEQRES 7 A 529 GLU ASN GLY GLU ARG THR ALA GLY SER ARG TRP GLU LEU SEQRES 8 A 529 ILE GLN THR ALA LEU LEU ASN LYS PHE THR ARG PRO GLN SEQRES 9 A 529 ASN LEU LYS ASP ALA ILE LEU LYS TYR ASN VAL ALA TYR SEQRES 10 A 529 SER LYS LYS TRP ASP PHE THR ALA LEU ILE ASP PHE TRP SEQRES 11 A 529 ASP LYS VAL LEU GLU GLU ALA GLU ALA GLN HIS LEU TYR SEQRES 12 A 529 GLN SER ILE LEU PRO ASP MET VAL LYS ILE ALA LEU CME SEQRES 13 A 529 LEU PRO ASN ILE CYS THR GLN PRO ILE PRO LEU LEU LYS SEQRES 14 A 529 GLN LYS MET ASN HIS SER ILE THR MET SER GLN GLU GLN SEQRES 15 A 529 ILE ALA SER LEU LEU ALA ASN ALA PHE PHE CYS THR PHE SEQRES 16 A 529 PRO ARG ARG ASN ALA LYS MET LYS SER GLU TYR SER SER SEQRES 17 A 529 TYR PRO ASP ILE ASN PHE ASN ARG LEU PHE GLU GLY ARG SEQRES 18 A 529 SER SER ARG LYS PRO GLU LYS LEU LYS THR LEU PHE CYS SEQRES 19 A 529 TYR PHE ARG ARG VAL THR GLU LYS LYS PRO THR GLY LEU SEQRES 20 A 529 VAL THR PHE THR ARG GLN SER LEU GLU ASP PHE PRO GLU SEQRES 21 A 529 TRP GLU ARG CYS GLU LYS PRO LEU THR ARG LEU HIS VAL SEQRES 22 A 529 THR TYR GLU GLY THR ILE GLU GLU ASN GLY GLN GLY MET SEQRES 23 A 529 LEU GLN VAL ASP PHE ALA ASN ARG PHE VAL GLY GLY GLY SEQRES 24 A 529 VAL THR SER ALA GLY LEU VAL GLN GLU GLU ILE ARG PHE SEQRES 25 A 529 LEU ILE ASN PRO GLU LEU ILE ILE SER ARG LEU PHE THR SEQRES 26 A 529 GLU VAL LEU ASP HIS ASN GLU CYS LEU ILE ILE THR GLY SEQRES 27 A 529 THR GLU GLN TYR SER GLU TYR THR GLY TYR ALA GLU THR SEQRES 28 A 529 TYR ARG TRP SER ARG SER HIS GLU ASP GLY SER GLU ARG SEQRES 29 A 529 ASP ASP TRP GLN ARG ARG CYS THR GLU ILE VAL ALA ILE SEQRES 30 A 529 ASP ALA LEU HIS PHE ARG ARG TYR LEU ASP GLN PHE VAL SEQRES 31 A 529 PRO GLU LYS MET ARG ARG GLU LEU ASN LYS ALA TYR CYS SEQRES 32 A 529 GLY PHE LEU ARG PRO GLY VAL SER SER GLU ASN LEU SER SEQRES 33 A 529 ALA VAL ALA THR GLY ASN TRP GLY CYS GLY ALA PHE GLY SEQRES 34 A 529 GLY ASP ALA ARG LEU LYS ALA LEU ILE GLN ILE LEU ALA SEQRES 35 A 529 ALA ALA ALA ALA GLU ARG ASP VAL VAL TYR PHE THR PHE SEQRES 36 A 529 GLY ASP SER GLU LEU MET ARG ASP ILE TYR SER MET HIS SEQRES 37 A 529 ILE PHE LEU THR GLU ARG LYS LEU THR VAL GLY ASP VAL SEQRES 38 A 529 TYR LYS LEU LEU LEU ARG TYR TYR ASN GLU GLU CYS ARG SEQRES 39 A 529 ASN CYS SER THR PRO GLY PRO ASP ILE LYS LEU TYR PRO SEQRES 40 A 529 PHE ILE TYR HIS ALA VAL GLU SER CYS ALA GLU THR ALA SEQRES 41 A 529 ASP HIS SER GLY GLN ARG THR GLY THR MODRES 6OAL CME A 603 CYS MODIFIED RESIDUE HET CME A 603 19 HET M0P A1001 41 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM M0P 1,3-DIMETHYL-8-{[2-(MORPHOLIN-4-YL)ETHYL]SULFANYL}-3,7- HETNAM 2 M0P DIHYDRO-1H-PURINE-2,6-DIONE FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 M0P C13 H19 N5 O3 S FORMUL 3 HOH *359(H2 O) HELIX 1 AA1 PRO A 457 MET A 461 5 5 HELIX 2 AA2 ARG A 485 LEU A 489 5 5 HELIX 3 AA3 SER A 534 LEU A 544 1 11 HELIX 4 AA4 ARG A 549 TYR A 560 1 12 HELIX 5 AA5 ASN A 561 SER A 565 5 5 HELIX 6 AA6 PHE A 570 VAL A 580 1 11 HELIX 7 AA7 GLU A 582 SER A 592 1 11 HELIX 8 AA8 SER A 592 CME A 603 1 12 HELIX 9 AA9 CME A 603 CYS A 608 1 6 HELIX 10 AB1 GLN A 627 PHE A 639 1 13 HELIX 11 AB2 PHE A 661 GLU A 666 5 6 HELIX 12 AB3 SER A 670 LYS A 689 1 20 HELIX 13 AB4 GLU A 707 CYS A 711 5 5 HELIX 14 AB5 THR A 725 GLY A 730 1 6 HELIX 15 AB6 VAL A 753 ASN A 762 1 10 HELIX 16 AB7 PRO A 763 ILE A 766 5 4 HELIX 17 AB8 ILE A 767 THR A 772 1 6 HELIX 18 AB9 TYR A 795 TYR A 799 5 5 HELIX 19 AC1 ARG A 831 PHE A 836 5 6 HELIX 20 AC2 VAL A 837 LEU A 853 1 17 HELIX 21 AC3 SER A 858 LEU A 862 5 5 HELIX 22 AC4 CYS A 872 GLY A 876 5 5 HELIX 23 AC5 ASP A 878 ALA A 893 1 16 HELIX 24 AC6 ASP A 904 ARG A 921 1 18 HELIX 25 AC7 THR A 924 CYS A 940 1 17 HELIX 26 AC8 LYS A 951 GLU A 961 1 11 SHEET 1 AA110 TRP A 453 GLY A 455 0 SHEET 2 AA110 LEU A 718 THR A 721 -1 O VAL A 720 N LEU A 454 SHEET 3 AA110 VAL A 897 PHE A 900 1 O TYR A 899 N HIS A 719 SHEET 4 AA110 VAL A 865 GLY A 868 1 N VAL A 865 O VAL A 898 SHEET 5 AA110 LEU A 734 ALA A 739 1 N LEU A 734 O ALA A 866 SHEET 6 AA110 GLU A 820 ASP A 825 1 O VAL A 822 N ASP A 737 SHEET 7 AA110 GLU A 779 THR A 784 -1 N ILE A 783 O ILE A 821 SHEET 8 AA110 LEU A 694 SER A 701 -1 N THR A 698 O ILE A 782 SHEET 9 AA110 HIS A 621 SER A 626 -1 N ILE A 623 O PHE A 697 SHEET 10 AA110 HIS A 480 VAL A 482 1 N THR A 481 O THR A 624 SHEET 1 AA2 2 SER A 790 THR A 793 0 SHEET 2 AA2 2 ARG A 800 SER A 804 -1 O SER A 802 N GLU A 791 LINK C LEU A 602 N CME A 603 1555 1555 1.32 LINK C CME A 603 N LEU A 604 1555 1555 1.32 CISPEP 1 MET A 464 PRO A 465 0 5.09 CISPEP 2 PHE A 498 PRO A 499 0 2.82 SITE 1 AC1 13 THR A 725 ILE A 726 GLU A 727 PHE A 738 SITE 2 AC1 13 VAL A 753 GLN A 754 TYR A 792 TYR A 795 SITE 3 AC1 13 ASN A 869 PHE A 900 PHE A 902 HOH A1195 SITE 4 AC1 13 HOH A1212 CRYST1 66.302 89.053 94.290 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015083 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011229 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010606 0.00000